Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Mahesh, Iddawela"'
Publikováno v:
JCO Global Oncology, Vol , Iss 6, Pp 124-132 (2020)
PURPOSE To explore the cancer diagnosis, treatment, and survivorship experiences of Aboriginal people in the Gippsland region, Victoria, Australia, and identify factors critical to the development of a culturally appropriate cancer survivorship model
Externí odkaz:
https://doaj.org/article/f3cf2c0b280946c0b1a90e27a19186e3
Autor:
Eli Ristevski, Teralynn Ludwick, Michael Leach, Sharyn Thompson, Mahesh Iddawela, Michelle Pryce, Elaine Wood, Kerry Davidson, Joanne Gell
Publikováno v:
International Journal of Integrated Care, Vol 22, Iss 1 (2022)
Objective: In 2018, the Optimal Care Pathway (OCP) for Aboriginal and Torres Strait Islander people with cancer was developed in Australia to improve the cancer care experiences and outcomes of Aboriginal and Torres Strait Islander people. Methods: O
Externí odkaz:
https://doaj.org/article/b53bba323d634e68b6013a559e127ba1
Autor:
Mahesh Iddawela, Oscar Rueda, Jenny Eremin, Oleg Eremin, Jed Cowley, Helena M. Earl, Carlos Caldas
Publikováno v:
BMC Genomics, Vol 18, Iss 1, Pp 1-13 (2017)
Abstract Background An absence of reliable molecular markers has hampered individualised breast cancer treatments, and a major limitation for translational research is the lack of fresh tissue. There are, however, abundant banks of formalin-fixed par
Externí odkaz:
https://doaj.org/article/d6df67b915af409e9988856c24d53bbc
Autor:
Bishal Gyawali, Mahesh Iddawela
Publikováno v:
Journal of Global Oncology, Vol 3, Iss 2, Pp 93-97 (2017)
Bevacizumab became the first molecular antibody to show survival benefit in advanced cervical cancer. In the GOG-0240 (Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cer
Externí odkaz:
https://doaj.org/article/236ea14c69e440a39030318196557261
Autor:
Julia N Morris, Fiona Crawford‐Williams, Bogda Koczwara, Raymond J Chan, Janette Vardy, Karolina Lisy, Mahesh Iddawela, Gillian Mackay, Michael Jefford
Publikováno v:
Asia-Pacific Journal of Clinical Oncology.
Publikováno v:
JCO Global Oncology
PURPOSE To explore the cancer diagnosis, treatment, and survivorship experiences of Aboriginal people in the Gippsland region, Victoria, Australia, and identify factors critical to the development of a culturally appropriate cancer survivorship model
Autor:
Richard J. Cohn, Bogda Koczwara, Joel Rhee, David Joske, Janette L. Vardy, Raymond J. Chan, Mahesh Iddawela, Elysia Thornton-Benko
Publikováno v:
Australian journal of general practice. 50(8)
BACKGROUND: Advances in cancer treatment have not benefited all patients equally, underscoring the need for a personalised approach to care. OBJECTIVE: The aim of this article is to outline the key elements of personalised cancer care, including deli
Autor:
Fiona Crawford-Williams, Bogda Koczwara, Raymond J. Chan, Janette Vardy, Karolina Lisy, Julia Morris, Mahesh Iddawela, Gillian Mackay, Michael Jefford
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 30(5)
The aim of this study was to establish research and infrastructure priorities for cancer survivorship.A two-round modified online Delphi study was completed by Australian experts in cancer survivorship. Initial priorities were generated from the lite
Publikováno v:
BJU International. 124:50-56
Objective To characterize circulating oestrogen receptor ( ER) mutants and splice variants in men with advanced prostate cancer. Materials and methods Sequential blood samples were obtained from men with advanced prostate cancer, and from healthy con
Autor:
Bristi Basu, Helen Hatcher, Helena M. Earl, Sue Freeman, Ioannis Gounaris, Penny Moyle, Christine Parkinson, Karen Sayal, James D. Brenton, Mercedes Jimenez-Linan, Mahesh Iddawela, Jean Abraham, Karen Hosking
Publikováno v:
International Journal of Gynecological Cancer
Supplemental digital content is available in the text.
Objective Primary platinum-resistant epithelial ovarian cancer (EOC) is an area of unmet medical need. There is limited evidence from small studies that platinum-based combinations can overc
Objective Primary platinum-resistant epithelial ovarian cancer (EOC) is an area of unmet medical need. There is limited evidence from small studies that platinum-based combinations can overc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e1e8ba10410815470a721963da62e5b